Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Dr. Leor Weinberger discusses possible treatments for Ebola with ABC 7 News and stresses the need for research into new anti-virals that can treat a broad range of infections.
The ALS Association announces initial commitment of $21.7 million from Ice Bucket Challenge donations to expedite search for treatments and a cure for ALS
Gladstone investigator Dr. Steven Finkbeiner is part of a consortium receiving funding from the ALS Association Ice Bucket Challenge donations, investigating new potential treatments for ALS.
Dr. Deepak Srivastava, Director of the Gladstone Institute of Cardiovascular Disease, discusses the future of cardiac reprogramming, the potentially life-saving technique that he pioneered.
The Gladstone Institutes Dr. Robert Grant, who led the research on Truvada, confirms that the drug is safe and highly effective.
Gladstone senior investigator Dr. Robert Grant recommends PrEP for HIV prevention be used like contraception.
Dr. Warner Greene discusses the need for better health care systems in Africa with the current Ebola outbreak.
Gladstone Institute of Virology and Immunology director Dr. Warner Greene says best way to stop the Ebola virus is through basic prevention techniques.
Scientists can now spot the signs of dementia a lot earlier than ever before, by looking at your eyes. They’ve found that degeneration of the eye, or retina, is linked to the parts of the brain affected by the disease.
Warner Greene, Director of the Gladstone Institute of Virology and Immunology, quoted in the San Francisco Business Times about the recent Ebola outbreak and the risk for infection here in the U.S.
The Director of the Gladstone Institute of Virology and Immunology, Warner Greene, comments on the recent Ebola outbreak in West Africa and the appropriate response to a possible patient in Sacramento.